Effects of CpG oligodeoxynucleotides on enhancing immune response in patients infected with hepatitis B virus

Ning LI,Xue-gong FAN,Cai ZHU,Ruo-su YING,Yan HUANG

DOI: https://doi.org/10.3969/j.issn.1000-8861.2007.05.010

2007-01-01

Abstract:Objective To investigate the effects of synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG dinucleotides (CpG-ODN) on enhancing immune response in PBMCs of patients infected with hepatitis B virus (HBV). Methods CpG-ODN was co-cultured with peripheral blood mononuclear cells (PBMCs) obtained from healthy controls and individuals infected with HBV, and the levels of IFN-α in the culture supernatants were measured by ELISA. The culture supernatants of PBMCs were added to HBV-transfected HepG2.2.15 cells with various ratios. Levels of HBsAg, HBeAg, and HBV DNA in culture supernatant of HepG2.2.15 cells were detected by ELISA and fluorescence quantitative PCR at day 4 and 8. MTT method was used to detect lytic activity of HepG2.2.15 cells mediated by the culture supernatants of CpG-ODN-stimulated PBMCs. Results CpG-ODN induced high amounts of IFN-α production. The lysis of HepG2.2.15 cells mediated by the culture supernatants of CpG-ODN-stimulated PBMC was increased. CpG-ODN alone could not inhibit HBV replication directly, but the culture supernatant of PMBCs activated with CpG-ODN could remarkably inhibit the production of HBsAg, HBeAg and HBV DNA by HepG2.2.15 cells. Conclusion CpG-ODN can efficiently increase the immune response of chronic hepatitis B patients and enhance the anti-HBV effects.